Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum

Thromboembolism is a common and deadly consequence of COVID-19 infection for hospitalized patients. Based on clinical evidence pre-dating the COVID-19 pandemic and early observational reports, expert consensus and guidance documents have strongly encouraged the use of prophylactic anticoagulation fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnes, Geoffrey D, Burnett, Allison, Allen, Arthur, Ansell, Jack, Blumenstein, Marilyn, Clark, Nathan P, Crowther, Mark, Dager, William E, Deitelzweig, Steven B., Ellsworth, Stacy, Garcia, David, Kaatz, Scott, Raffini, Leslie, Rajasekhar, Anita, Beek, Andrea Van, Minichiello, Tracy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111941/
https://www.ncbi.nlm.nih.gov/pubmed/35579732
http://dx.doi.org/10.1007/s11239-022-02643-3
_version_ 1784709320665989120
author Barnes, Geoffrey D
Burnett, Allison
Allen, Arthur
Ansell, Jack
Blumenstein, Marilyn
Clark, Nathan P
Crowther, Mark
Dager, William E
Deitelzweig, Steven B.
Ellsworth, Stacy
Garcia, David
Kaatz, Scott
Raffini, Leslie
Rajasekhar, Anita
Beek, Andrea Van
Minichiello, Tracy
author_facet Barnes, Geoffrey D
Burnett, Allison
Allen, Arthur
Ansell, Jack
Blumenstein, Marilyn
Clark, Nathan P
Crowther, Mark
Dager, William E
Deitelzweig, Steven B.
Ellsworth, Stacy
Garcia, David
Kaatz, Scott
Raffini, Leslie
Rajasekhar, Anita
Beek, Andrea Van
Minichiello, Tracy
author_sort Barnes, Geoffrey D
collection PubMed
description Thromboembolism is a common and deadly consequence of COVID-19 infection for hospitalized patients. Based on clinical evidence pre-dating the COVID-19 pandemic and early observational reports, expert consensus and guidance documents have strongly encouraged the use of prophylactic anticoagulation for patients hospitalized for COVID-19 infection. More recently, multiple clinical trials and larger observational studies have provided evidence for tailoring the approach to thromboprophylaxis for patients with COVID-19. This document provides updated guidance for the use of anticoagulant therapies in patients with COVID-19 from the Anticoagulation Forum, the leading North American organization of anticoagulation providers. We discuss ambulatory, in-hospital, and post-hospital thromboprophylaxis strategies as well as provide guidance for patients with thrombotic conditions who are considering COVID-19 vaccination. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11239-022-02643-3.
format Online
Article
Text
id pubmed-9111941
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-91119412022-05-17 Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum Barnes, Geoffrey D Burnett, Allison Allen, Arthur Ansell, Jack Blumenstein, Marilyn Clark, Nathan P Crowther, Mark Dager, William E Deitelzweig, Steven B. Ellsworth, Stacy Garcia, David Kaatz, Scott Raffini, Leslie Rajasekhar, Anita Beek, Andrea Van Minichiello, Tracy J Thromb Thrombolysis Article Thromboembolism is a common and deadly consequence of COVID-19 infection for hospitalized patients. Based on clinical evidence pre-dating the COVID-19 pandemic and early observational reports, expert consensus and guidance documents have strongly encouraged the use of prophylactic anticoagulation for patients hospitalized for COVID-19 infection. More recently, multiple clinical trials and larger observational studies have provided evidence for tailoring the approach to thromboprophylaxis for patients with COVID-19. This document provides updated guidance for the use of anticoagulant therapies in patients with COVID-19 from the Anticoagulation Forum, the leading North American organization of anticoagulation providers. We discuss ambulatory, in-hospital, and post-hospital thromboprophylaxis strategies as well as provide guidance for patients with thrombotic conditions who are considering COVID-19 vaccination. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11239-022-02643-3. Springer US 2022-05-17 2022 /pmc/articles/PMC9111941/ /pubmed/35579732 http://dx.doi.org/10.1007/s11239-022-02643-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Barnes, Geoffrey D
Burnett, Allison
Allen, Arthur
Ansell, Jack
Blumenstein, Marilyn
Clark, Nathan P
Crowther, Mark
Dager, William E
Deitelzweig, Steven B.
Ellsworth, Stacy
Garcia, David
Kaatz, Scott
Raffini, Leslie
Rajasekhar, Anita
Beek, Andrea Van
Minichiello, Tracy
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
title Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
title_full Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
title_fullStr Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
title_full_unstemmed Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
title_short Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
title_sort thromboembolic prevention and anticoagulant therapy during the covid-19 pandemic: updated clinical guidance from the anticoagulation forum
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111941/
https://www.ncbi.nlm.nih.gov/pubmed/35579732
http://dx.doi.org/10.1007/s11239-022-02643-3
work_keys_str_mv AT barnesgeoffreyd thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum
AT burnettallison thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum
AT allenarthur thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum
AT anselljack thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum
AT blumensteinmarilyn thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum
AT clarknathanp thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum
AT crowthermark thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum
AT dagerwilliame thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum
AT deitelzweigstevenb thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum
AT ellsworthstacy thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum
AT garciadavid thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum
AT kaatzscott thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum
AT raffinileslie thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum
AT rajasekharanita thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum
AT beekandreavan thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum
AT minichiellotracy thromboembolicpreventionandanticoagulanttherapyduringthecovid19pandemicupdatedclinicalguidancefromtheanticoagulationforum

Ejemplares similares